-
Stocks That Are Affected By Hurricane Season
Wednesday, August 31, 2016 - 11:02am | 527Read More...Wednesday's edition of Benzinga's PreMarket Prep featured an interesting conversation on what stocks are affected by hurricane season. Two hurricanes, Lester and Madeline, are honing in Hawaii and residents are being encouraged to stockpile on water and emergency supplies ahead of what...
-
How A Tornado Changed One Trader's Mind About Twitter
Thursday, August 25, 2016 - 8:17pm | 520Read More...A tornado touched down just outside Windsor, Ontario Wednesday night. Nobody was hurt, but the sudden storm did have one unintentional effect. Dennis Dick, a veteran trader and co-host of Benzinga's PreMarket Prep, has been mostly bearish on Twitter Inc (NYSE: TWTR) since its IPO, even...
-
Risk Arbitrage Trading Strategies
Wednesday, August 24, 2016 - 10:56am | 677Read More...There’s a whole class of traders out there that trade merger & acquisition (M&A) rumors and news. When one company makes a buyout bid for another company, the bid is typically priced at a premium to the target company’s market value at the time of the bid. As a result, buyout...
-
How To Trade Gaps In Price Action
Wednesday, August 17, 2016 - 1:23pm | 597Read More...There’s no worse feeling as a stock trader than when a stock you’ve been watching gaps up or down, and you feel like you missed the big move. However, gap traders know that these scenarios often present golden gap-trading opportunities. Premarket Prep’s Dennis Dick and Joel...
-
The Ins And Outs Of Dividend Capture Strategy
Tuesday, August 16, 2016 - 12:40pm | 575Read More...Investors often think of dividend payments as a somewhat boring long-term advantage to owning certain stocks that have relatively strong cash flow. However, quarterly dividend payments can also provide short-term trading opportunities. Dividend Capture Strategy The dividend capture strategy is a...
-
Mirror Image: Bristol-Myers Loss Is Merck's Potential Gain
Tuesday, August 16, 2016 - 10:11am | 283Read More...In the past week, Bristol-Myers Squibb Co's (NYSE: BMY) loss has been Merck & Co., Inc.'s (NYSE: MRK) gain. When Bristol-Myers reported back on August 5 that Opdivo did not meet its targets for treatment of advanced non-small cell lung cancer, the stock tanked 16 percent. Merck...
-
SolarCity's Downside Risk Is A Lot More Significant Than Its Upside Potential Until Tesla Deal Is Official
Monday, August 1, 2016 - 12:14pm | 331Read More...Tesla Motors Inc (NASDAQ: TSLA) has officially made a new $2.6 billion stock bid for SolarCity Corp (NASDAQ: SCTY), but SolarCity shareholder’s aren’t particularly pleased with the terms of the deal. Tesla announced on Monday that SolarCity shareholders would receive 0.11 shares of...
-
Oracle Goes From Green To Red After Acquisition Of NetSuite
Thursday, July 28, 2016 - 1:48pm | 489Read More...Oracle Corporation (NYSE: ORCL) has announced a huge deal to expand its cloud business by buying NetSuite Inc (NYSE: N) for $9.3 billion. “Oracle and NetSuite could applications are complementary and will coexist in the marketplace forever,” Oracle CEO Mark Hurd said in a statement....
-
How Some ZIOP Buyers Got Screwed On Thursday Night
Friday, July 15, 2016 - 12:41pm | 961Read More...Shares of ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) sold off hard Thursday afternoon after The Street's Adam Feuerstein tweeted that a funding attempt had been abandoned, and brain cancer patient had died after receiving an injection of the company's gene therapy drug. But some traders...
-
Wall Street Vet Downplays Skepticism Of Goldman's Tesla Upgrade: 'Just Doesn't Make Any Sense'
Thursday, May 19, 2016 - 12:30pm | 277Read More...PreMarket Prep host Dennis Dick downplayed skepticism of Goldman Sachs Group Inc (NYSE: GS) intentionally upgrading Tesla Motros Inc (NASDAQ: TSLA) to reach a better secondary price for Goldman-led financing with Tesla. "I don't think the risk reward was there to intentionally upgrade...
-
Is The Efficient Market Hypothesis Nonsense?
Tuesday, May 10, 2016 - 4:39pm | 313Read More...The efficient market hypothesis (EMH) is an investment principle which argues that it's impossible for investors to beat the market because the stock market is so efficient and any change in share price accurately incorporates and reflects all news and information. Is this nonesense?...
-
Strength In Sarepta: Why Today's Moves Were Predictable
Tuesday, April 26, 2016 - 5:26pm | 535Read More...Sarepta Therapeutics Inc (NASDAQ: SRPT) shares are trading lower by $4.09 at $10.86 in Tuesday's session. The catalyst for the decline is likely a vote by the FDA against Duchenne Muscular Dystrophy drug, Eteplirsen. But in the face of this bearish news, PreMarket Prep hosts Joel Elconin and...
-
Happy 420! Here's How To Invest In Legal Marijuana
Wednesday, April 20, 2016 - 4:20pm | 502Read More...Happy 420! Even though marijuana is not legal at the federal level, those interested in taking part in Wacky Weed Day's festivities can do so through investing. On Wednesday, Benzinga's PreMarket Prep hosts Joel Elconin and Dennis Dick were joined by Alan Brochstein, the "420...
-
No Doha Deal? No Problem for Oil
Wednesday, April 20, 2016 - 8:32am | 458Read More...The news over the weekend that no deal could be reached in Doha to cut the global production of oil may have caused some investors to worry. But, if the last two days are any indication, they've quickly gotten over it. Crude oil futures are up two points since they opened this week, and...
-
Under Armour Loses Some Shine Amid Spieth's Epic Collapse At The Masters
Monday, April 11, 2016 - 12:27pm | 785Read More...Under Armour Inc (NYSE: UA) shares were trading lower by $2 (4.8 percent) at $41.55 in Monday's session. One catalyst for the decline? Jordan Spieth's collapse on the back nine of the 2016 Masters. The Collapse After taking a seemingly insurmountable five-stroke lead into the back...















